StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
81
This month
1
This week
1
This year
7
Yesterday
1
Publishing Date
2023 - 11 - 02
3
2023 - 10 - 25
2
2023 - 08 - 03
2
2023 - 07 - 19
1
2023 - 07 - 17
1
2023 - 05 - 04
1
2023 - 04 - 20
1
2023 - 02 - 23
2
2023 - 02 - 02
1
2022 - 11 - 03
1
2022 - 10 - 27
1
2022 - 10 - 13
1
2022 - 09 - 08
1
2022 - 08 - 29
1
2022 - 08 - 11
1
2022 - 08 - 09
1
2022 - 08 - 03
1
2022 - 07 - 28
1
2022 - 07 - 18
1
2022 - 06 - 09
1
2022 - 06 - 02
1
2022 - 05 - 24
1
2022 - 05 - 23
1
2022 - 04 - 28
1
2022 - 04 - 14
1
2022 - 02 - 24
1
2022 - 02 - 10
1
2022 - 01 - 24
1
2022 - 01 - 21
2
2022 - 01 - 14
1
2021 - 12 - 14
1
2021 - 12 - 13
1
2021 - 12 - 12
1
2021 - 12 - 09
1
2021 - 11 - 13
1
2021 - 11 - 09
1
2021 - 11 - 05
2
2021 - 10 - 28
1
2021 - 10 - 27
1
2021 - 10 - 19
1
2021 - 10 - 14
1
2021 - 10 - 04
1
2021 - 09 - 10
1
2021 - 09 - 07
1
2021 - 08 - 09
1
2021 - 08 - 05
1
2021 - 08 - 03
1
2021 - 08 - 02
1
2021 - 07 - 21
2
2021 - 05 - 15
1
2021 - 05 - 03
2
2021 - 04 - 29
1
2021 - 04 - 19
2
2021 - 04 - 15
1
2021 - 04 - 11
1
2021 - 04 - 10
1
2021 - 03 - 31
1
2021 - 03 - 23
1
2021 - 01 - 28
1
2021 - 01 - 07
1
Sector
Health technology
81
Tags
Alliances
1
Als
1
Alzheimer’s
2
Biotech
1
Biotech-bay
5
Blood
1
Cardiac
1
Cardiology
1
Cardiovascular
1
Care
1
Clinical-trials-phase-i
1
Clinical-trials-phase-ii
1
Clinical-trials-phase-iii
7
Conference
13
Disease
3
Earnings
21
Events
7
Financial
21
Financial results
13
First
1
Genetic
1
Genetown
12
Givlaari
1
Hypertension
1
Iot
1
Kidney
2
Liver
1
Liver disease
1
N/a
22
Nephropathy
2
Oxlumo
1
Pharmaceutical
1
Pharmaceuticals
5
Phase 1
3
Phase 2
5
Phase 3
19
Positive
15
Positive results
2
Pre-clinical
1
Preclinical
1
Presentation
1
Publication
3
Report
2
Research
3
Results
79
Risk
1
Study
8
System
1
Tcom
1
Technology
2
Therapeutics
1
Topline
7
Treat
1
Treatment
4
Trial
2
Update
6
Year
7
Entities
2seventy bio, inc.
1
Abbvie inc.
1
Alnylam pharmaceuticals, inc.
81
Biogen inc.
1
Checkmate pharmaceuticals, inc.
1
Eli lilly and company
6
Gilead sciences, inc.
1
Intellia therapeutics, inc.
2
Ionis pharmaceuticals, inc.
2
Johnson & johnson
2
Moderna, inc.
1
Novo nordisk a/s
6
Pfizer, inc.
1
Pulse biosciences, inc
1
Reata pharmaceuticals, inc.
1
Regeneron pharmaceuticals, inc.
6
Sanofi
28
Summit therapeutics inc.
1
Vir biotechnology, inc.
6
Xencor, inc.
4
Symbols
ABBV
92
AEM
51
ALNY
81
AMGN
55
APO
41
ARVL
197
AUY
47
BAM
54
BGNE
52
BMO
41
BMY
73
BNPQF
82
BNPQY
82
BNTX
54
BTG
44
CHRS
48
CYTK
44
DAO
46
ENB
42
FBIO
61
FNCTF
374
FRBA
95
GILD
55
GMAB
48
GOLD
50
INCY
77
IONS
43
JD
43
JKS
42
JNJ
248
LGND
46
LLY
219
LTUM
61
LXRX
41
MDT
45
MDWD
53
MPC
55
MPLX
53
MS
225
NEE
49
NEP
48
NTES
59
NVS
59
NVSEF
44
PAYD
198
PFE
64
PPRUF
89
PPRUY
89
PRVB
46
REGN
88
SNY
393
SNYNF
315
TAK
71
TEVJF
53
TK
49
TNK
48
TTOO
44
UAN
52
XNCR
42
XYF
104
Exchanges
Nasdaq
81
Nyse
10
Crawled Date
2023 - 11 - 02
2
2023 - 10 - 25
2
2023 - 08 - 03
2
2023 - 07 - 20
1
2023 - 07 - 19
1
2023 - 07 - 17
1
2023 - 05 - 04
1
2023 - 04 - 20
1
2023 - 02 - 23
2
2023 - 02 - 02
1
2022 - 11 - 03
1
2022 - 10 - 27
1
2022 - 10 - 13
1
2022 - 09 - 08
1
2022 - 08 - 29
1
2022 - 08 - 11
1
2022 - 08 - 09
1
2022 - 08 - 03
1
2022 - 07 - 28
1
2022 - 07 - 18
1
2022 - 06 - 09
1
2022 - 06 - 02
1
2022 - 05 - 24
1
2022 - 05 - 23
1
2022 - 04 - 28
1
2022 - 04 - 14
1
2022 - 02 - 25
1
2022 - 02 - 10
1
2022 - 01 - 24
1
2022 - 01 - 21
2
2022 - 01 - 14
1
2021 - 12 - 14
2
2021 - 12 - 12
1
2021 - 12 - 09
1
2021 - 11 - 13
1
2021 - 11 - 09
1
2021 - 11 - 05
2
2021 - 10 - 28
1
2021 - 10 - 27
1
2021 - 10 - 19
1
2021 - 10 - 14
1
2021 - 10 - 04
1
2021 - 09 - 10
1
2021 - 09 - 07
1
2021 - 08 - 09
1
2021 - 08 - 05
1
2021 - 08 - 03
1
2021 - 08 - 02
1
2021 - 07 - 21
2
2021 - 05 - 15
1
2021 - 05 - 03
2
2021 - 04 - 29
1
2021 - 04 - 19
2
2021 - 04 - 15
1
2021 - 04 - 11
1
2021 - 04 - 10
1
2021 - 03 - 31
1
2021 - 03 - 23
1
2021 - 01 - 28
1
2021 - 01 - 07
1
Crawled Time
00:00
3
01:00
1
03:00
1
04:20
1
08:00
1
09:00
1
10:00
1
11:00
1
12:00
8
12:15
2
12:20
2
12:30
1
13:00
16
13:15
2
13:20
3
13:30
1
14:00
5
14:30
3
15:00
4
15:30
1
16:00
2
16:20
2
18:00
2
19:00
4
20:00
1
20:20
2
21:00
2
22:00
6
23:00
2
Source
www.alnylam.com
16
www.biospace.com
59
www.globenewswire.com
6
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
results
symbols :
Alny
save search
Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results
Published:
2024-04-18
(Crawled : 19:00)
- biospace.com/
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-1.57%
|
O:
-1.17%
H:
1.01%
C:
0.11%
first
conference
financial
results
Alnylam to Webcast Investor Event to Discuss Results from KARDIA-2 Phase 2 Study of Zilebesiran at American College of Cardiology Scientific Session
Published:
2024-03-20
(Crawled : 13:00)
- biospace.com/
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-2.54%
|
O:
-0.11%
H:
0.43%
C:
-0.01%
cardiology
results
study
Alnylam Reports Positive KARDIA-2 Topline Study Results Demonstrating Clinically Significant Blood Pressure Reductions When Zilebesiran is Added to Standard of Care Antihypertensives
Published:
2024-03-05
(Crawled : 16:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.49%
|
O:
1.17%
H:
0.0%
C:
0.0%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-3.75%
|
O:
-0.73%
H:
1.52%
C:
0.5%
positive
blood
care
topline
results
study
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-02-22
(Crawled : 00:00)
- biospace.com/
XNCR
|
$18.385
-2.98%
-3.07%
830K
|
Health Technology
|
-23.7%
|
O:
-0.87%
H:
2.89%
C:
2.14%
VIR
|
$7.96
0.0%
1.1M
|
Health Technology
|
-21.36%
|
O:
-0.69%
H:
2.99%
C:
2.59%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-6.68%
|
O:
-0.17%
H:
6.18%
C:
5.4%
year
update
financial
results
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Period Activity
Published:
2024-02-15
(Crawled : 14:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
2.49%
|
O:
1.16%
H:
1.48%
C:
0.89%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
1.4%
|
O:
1.86%
H:
0.0%
C:
0.0%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-12.03%
|
O:
-8.62%
H:
2.18%
C:
-1.71%
year
pharmaceuticals
financial
results
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
Published:
2024-02-02
(Crawled : 12:00)
- globenewswire.com
TSVT
|
$4.52
-2.59%
-2.65%
610K
|
|
-12.91%
|
O:
-1.16%
H:
9.94%
C:
2.34%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.46%
|
O:
-0.93%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
-6.36%
|
O:
1.4%
H:
0.28%
C:
-2.68%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-17.44%
|
O:
-1.23%
H:
1.0%
C:
0.17%
year
financial
results
Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-01-29
(Crawled : 14:30)
- biospace.com/
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-19.6%
|
O:
-0.27%
H:
1.32%
C:
1.02%
conference
year
financial
results
Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2023
Published:
2023-11-07
(Crawled : 15:00)
- biospace.com/
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
17.36%
|
O:
-0.28%
H:
0.0%
C:
0.0%
SMMT
A
|
$3.51
0.0%
1.7M
|
Health Technology
|
60.55%
|
O:
-0.46%
H:
6.68%
C:
-11.75%
PLSE
|
$7.2
-2.17%
-2.22%
180K
|
Health Technology
|
38.54%
|
O:
0.39%
H:
6.43%
C:
1.92%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-21.82%
|
O:
-0.82%
H:
0.73%
C:
-0.4%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-13.6%
|
O:
1.06%
H:
2.42%
C:
0.76%
therapeutics
financial
results
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
Published:
2023-11-02
(Crawled : 00:00)
- biospace.com/
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-0.71%
|
O:
-0.89%
H:
0.0%
C:
0.0%
XNCR
|
$18.385
-2.98%
-3.07%
830K
|
Health Technology
|
5.21%
|
O:
1.32%
H:
0.45%
C:
-1.19%
VIR
|
$7.96
0.0%
1.1M
|
Health Technology
|
2.05%
|
O:
1.03%
H:
4.07%
C:
4.07%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-8.02%
|
O:
3.4%
H:
0.57%
C:
-0.5%
update
financial
results
Alnylam Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Period Activity
Published:
2023-11-02
(Crawled : 13:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
1.45%
|
O:
3.0%
H:
0.0%
C:
0.0%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-8.02%
|
O:
3.4%
H:
0.57%
C:
-0.5%
pharmaceuticals
financial
results
Regeneron Reports Third Quarter 2023 Financial and Operating Results
Published:
2023-11-02
(Crawled : 11:00)
- globenewswire.com
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
1.45%
|
O:
3.0%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
13.34%
|
O:
0.08%
H:
4.96%
C:
3.4%
NTLA
|
$21.57
1.17%
1.16%
1.4M
|
Health Technology
|
-15.41%
|
O:
2.35%
H:
1.63%
C:
1.46%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-8.02%
|
O:
3.4%
H:
0.57%
C:
-0.5%
financial
results
Alnylam Announces Publication of Results from APOLLO-B Phase 3 Study of Patisiran in Patients with the Cardiomyopathy of ATTR Amyloidosis in the New England Journal of Medicine
Published:
2023-10-25
(Crawled : 23:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-10.43%
|
O:
0.4%
H:
1.29%
C:
1.29%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-11.62%
|
O:
1.43%
H:
0.64%
C:
-0.09%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-11.92%
|
O:
-1.28%
H:
0.58%
C:
-1.46%
publication
results
study
Alnylam Reports Additional Positive Interim Phase 1 Results for ALN-APP, in Development for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
Published:
2023-10-25
(Crawled : 19:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-10.43%
|
O:
0.4%
H:
1.29%
C:
1.29%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-11.62%
|
O:
1.43%
H:
0.64%
C:
-0.09%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-11.92%
|
O:
-1.28%
H:
0.58%
C:
-1.46%
disease
alzheimer’s
positive
results
Alnylam to Webcast Conference Call Discussing Third Quarter 2023 Financial Results
Published:
2023-10-19
(Crawled : 13:00)
- biospace.com/
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-12.52%
|
O:
0.13%
H:
0.23%
C:
-2.9%
conference
financial
results
Alnylam Reports Positive Topline Results from KARDIA-1 Phase 2 Dose-Ranging Study of Zilebesiran, an Investigational RNAi Therapeutic in Development to Treat Hypertension in Patients at High Cardiovascular Risk
Published:
2023-09-07
(Crawled : 14:30)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-12.11%
|
O:
1.03%
H:
0.0%
C:
0.0%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-28.31%
|
O:
-0.15%
H:
1.32%
C:
-0.02%
positive
treat
risk
topline
hypertension
cardiovascular
results
study
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
Published:
2023-08-03
(Crawled : 20:00)
- globenewswire.com
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-12.97%
|
O:
0.19%
H:
0.0%
C:
0.0%
XNCR
|
$18.385
-2.98%
-3.07%
830K
|
Health Technology
|
-21.28%
|
O:
7.75%
H:
4.65%
C:
-3.9%
VIR
|
$7.96
0.0%
1.1M
|
Health Technology
|
-43.09%
|
O:
-0.36%
H:
2.51%
C:
-2.16%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-24.03%
|
O:
-0.42%
H:
0.0%
C:
-1.97%
update
financial
results
Alnylam Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Period Activity
Published:
2023-08-03
(Crawled : 13:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-10.05%
|
O:
-1.6%
H:
0.11%
C:
0.11%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-11.21%
|
O:
-3.79%
H:
0.0%
C:
0.0%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-21.78%
|
O:
-1.35%
H:
5.58%
C:
4.38%
pharmaceuticals
financial
results
Alnylam to Webcast Conference Call Discussing Second Quarter 2023 Financial Results
Published:
2023-07-20
(Crawled : 13:00)
- biospace.com/
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-29.67%
|
O:
-0.48%
H:
1.1%
C:
-1.41%
conference
financial
results
Alnylam Announces Publication of Phase 1 Study Results for Zilebesiran in the New England Journal of Medicine
Published:
2023-07-19
(Crawled : 22:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-13.39%
|
O:
0.88%
H:
0.0%
C:
0.0%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-30.71%
|
O:
0.74%
H:
0.28%
C:
-2.21%
publication
results
study
Alnylam Reports Updated Positive Interim Phase 1 Results for ALN-APP, in Development for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
Published:
2023-07-17
(Crawled : 09:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-12.16%
|
O:
0.02%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
24.81%
|
O:
0.05%
H:
1.33%
C:
0.38%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-26.73%
|
O:
5.53%
H:
5.23%
C:
-2.49%
disease
alzheimer’s
positive
results
← Previous
1
2
3
4
5
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.